Edward P. Gelmann
1972–2024 年に発表
- 別表記
- EDWARD P. GELMANN
- 82
- 論文数
- 21,360
- 被引用数
- 78
- h 指数
- 82
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine53.7%
- Biochemistry, Genetics and Molecular Biology30.8%
- Immunology and Microbiology9.3%
- Neuroscience1%
- Computer Science0.7%
- Environmental Science0.6%
- その他3.9%
トピック
- Prostate Cancer Treatment and Research6.9%
- Prostate Cancer Diagnosis and Treatment3.7%
- Estrogen and related hormone effects2.2%
- HIV Research and Treatment2%
- Wnt/β-catenin signaling in development and cancer2%
- Cancer-related gene regulation1.8%
- その他81.4%
共著者
- Henry Masur9
- H. CLIFFORD LANE8
- Anthony S. Fauci7
- Douglas J. Reding7
- Marc E. Lippman7
- Philip C. Prorok7
- Richard B. Hayes7
- ABE M. MACHER6
- Cai Bowen6
- Cornelius Knabbe6
- John K. Gohagan6
- Paul F. Pinsky6
- Timothy R. Church6
- Barnett S. Kramer5
- Christine D. Berg5
- Dan L. Longo5
- David Chia5
- E. David Crawford5
- Flossie Wong‐Staal5
- Gerald L. Andriole5
- Heinz Voeller5
- Lukas Bubendorf5
- Robert B. Dickson5
- Robert C. Gallo5
全論文
- Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
著者: Philip C. Prorok, Gerald L. Andriole, Robert S. Bresalier, Saundra S. Buys, David Chia, E. David Crawford, Ronald Fogel, Edward P. Gelmann, Fred Gilbert, Marsha Hasson, Richard B. Hayes, Christine Cole Johnson, Jack S. Mandel, Albert Oberman, Barbara O’Brien, Martin M. Oken, Sameer Rafla, Douglas J. Reding, Wilmer M. Rutt, Joel L. Weissfeld, Lance Yokochi, John K. Gohagan - Controlled Clinical Trials 2000 被引用: 1,041
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
著者: Gerald L. Andriole, E. David Crawford, Robert L. Grubb, Saundra S. Buys, David Chia, Timothy R. Church, Mona N. Fouad, Edward P. Gelmann, Paul A. Kvale, Douglas J. Reding, Joel L. Weissfeld, Lance Yokochi, Barbara O’Brien, Jonathan D. Clapp, Joshua M. Rathmell, Thomas L. Riley, Richard B. Hayes, Barnett S. Kramer, Grant Izmirlian, Anthony B. Miller, Paul F. Pinsky, Philip C. Prorok, John K. Gohagan, Christine D. Berg - New England Journal of Medicine 2009 被引用: 2,917
- Molecular Biology of the Androgen Receptor
著者: Edward P. Gelmann - Journal of Clinical Oncology 2002 被引用: 938
- The Ubiquitin-Proteasome Pathway and Its Role in Cancer
著者: Aparna Mani, Edward P. Gelmann - Journal of Clinical Oncology 2005 被引用: 545
- Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
著者: Jennifer M. Croswell, Barnett S. Kramer, Aimée R. Kreimer, Philip C. Prorok, J.-L. Xu, Stuart G. Baker, Richard M. Fagerstrom, T. Riley, Jonathan D. Clapp, Christine D. Berg, John K. Gohagan, Gerald L. Andriole, David Chia, Timothy R. Church, E. David Crawford, Mona N. Fouad, Edward P. Gelmann, Lois Lamerato, Douglas J. Reding, Robert E. Schoen - The Annals of Family Medicine 2009 被引用: 153
- Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
著者: Cai Bowen, Lukas Bubendorf, Heinz Voeller, Rebecca Slack, Niels Willi, G Sauter, Thomas C. Gasser, Pasi Koivisto, Ernest E. Lack, Juha Kononen, Olli Kallioniemi, Edward P. Gelmann - 2000 被引用: 383
- Evidence of a Healthy Volunteer Effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
著者: Paul F. Pinsky, Anthony B. Miller, B S Kramer, Timothy R. Church, Douglas J. Reding, Philip C. Prorok, Edward P. Gelmann, Robert E. Schoen, Saundra S. Buys, Richard B. Hayes, Christine D. Berg - American Journal of Epidemiology 2007 被引用: 231
- Malignant Pheochromocytoma: Effective Treatment with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine
著者: Steven D. Averbuch, Caryn Steakley, R C Young, Edward P. Gelmann, D. S. Goldstein, Robin Stull, Harry R. Keiser - Annals of Internal Medicine 1988 被引用: 424
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
著者: Robert Yarchoan, KentJ. Weinhold, H. Kim Lyerly, Edward P. Gelmann, RobertM. Blum, G M Shearer, Hiroaki Mitsuya, JerryM. Collins, CharlesE. Myers, R W Klecker, P D Markham, DavidT. Durack, Sandra Nusinoff Lehrman, DavidW. Barry, MargaretA. Fischl, RobertC. Gallo, DaniP. Bolognesi, Samuel Broder - The Lancet 1986 被引用: 804
- Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings From the Initial Screening Round of a Randomized Trial
著者: G. L. Andriole, David L. Levin, E. David Crawford, Edward P. Gelmann, Paul F. Pinsky, David Chia, Barnett S. Kramer, Douglas J. Reding, Timothy R. Church, Robert L. Grubb, Grant Izmirlian, Lawrence R. Ragard, Jonathan D. Clapp, Philip C. Prorok, John K. Gohagan, for the PLCO Project Team - JNCI Journal of the National Cancer Institute 2005 被引用: 243
- Lung cancer screening as a teachable moment for smoking cessation
著者: Kathryn L. Taylor, Lisa Sanderson Cox, Nicole L. Zincke, Larina Mehta, Colleen McGuire, Edward P. Gelmann - Lung Cancer 2006 被引用: 215
- Antiandrogen Effects of Mifepristone on Coactivator and Corepressor Interactions with the Androgen Receptor
著者: Liang‐Nian Song, Meghan Coghlan, Edward P. Gelmann - Molecular Endocrinology 2003 被引用: 118
- Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer Cells
著者: Shyh‐Han Tan, Ayush Dagvadorj, Feng Shen, Lei Gu, Zhiyong Liao, Junaid Abdulghani, Ying Zhang, Edward P. Gelmann, Tobias Zellweger, Zoran Čulig, Tapio Visakorpi, Lukas Bubendorf, Robert A. Kirken, James G. Karras, Marja T. Nevalainen - Cancer Research 2008 被引用: 105
- Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression
著者: Cai Bowen, Michael C. Ostrowski, Gustavo Leone, Edward P. Gelmann - Cancer Research 2019 被引用: 30
- A Novel Human Prostate-Specific, Androgen-Regulated Homeobox Gene (NKX3.1) That Maps to 8p21, a Region Frequently Deleted in Prostate Cancer
著者: Wei He, Peter J. Sciavolino, John Wing, Meena Augustus, Peter Hudson, Petra Meissner, R. Curtis, Brenda K. Shell, David G. Bostwick, Donald J. Tindall, Edward P. Gelmann, Cory Abate‐Shen, Kenneth C. Carter - Genomics 1997 被引用: 360
- Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.
著者: Cristina I. Truica, Stephen W. Byers, Edward P. Gelmann - 2000 被引用: 350
- p53 oncogene mutations in three human prostate cancer cell lines
著者: Alan G. Carroll, Heinz Voeller, Lavencia Sugars, Edward P. Gelmann - The Prostate 1993 被引用: 303
- Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer
著者: John K. Gohagan, Pamela M. Marcus, Richard M. Fagerstrom, Paul F. Pinsky, Barnett S. Kramer, Philip C. Prorok, Susan M. Ascher, William C. Bailey, Brenda Brewer, Timothy R. Church, Deborah Engelhard, Melissa Ford, Mona N. Fouad, Matthew T. Freedman, Edward P. Gelmann, David S. Gierada, William G. Hocking, Subbarao Inampudi, Brian K. Irons, Christine Cole Johnson, Arthur Jones, Gena Kucera, Paul A. Kvale, Karen Lappe, William Manor, Alisha Moore, Hrudaya Nath, Sarah Neff, Martin M. Oken, Michael Plunkett, Helen Price, Douglas J. Reding, Thomas Riley, Martin L. Schwartz, David L. Spizarny, Roberta Yoffie, Carl J. Zylak - Lung Cancer 2004 被引用: 302
- Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
著者: Ulrike Peters, Michael F. Leitzmann, Nilanjan Chatterjee, Yinghui Wang, Demetrius Albanes, Edward P. Gelmann, Marlin D. Friesen, Elio Ríboli, Richard B. Hayes - Cancer Epidemiology Biomarkers & Prevention 2007 被引用: 171
- NKX3.1 Activates Cellular Response to DNA Damage
著者: Cai Bowen, Edward P. Gelmann - Cancer Research 2010 被引用: 75
- Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
著者: Meredith Yeager, Nick Orr, Richard B. Hayes, Kevin B. Jacobs, Peter Kraft, Sholom Wacholder, Mark J Minichiello, Paul Fearnhead, Kai Yu, Nilanjan Chatterjee, Zhaoming Wang, Robert Welch, Brian Staats, Eugenia E. Calle, Heather Spencer Feigelson, Michael J. Thun, Carmen Rodríguez, Demetrius Albanes, Jarmo Virtamo, Stephanie J. Weinstein, Fredrick R. Schumacher, Edward L. Giovannucci, Walter C. Willett, Géraldine Cancel‐Tassin, Olivier Cussenot, Antoine Valéri, Gerald L. Andriole, Edward P. Gelmann, Margaret A. Tucker, Daniela S. Gerhard, Joseph F. Fraumeni, Robert N. Hoover, David J. Hunter, Stephen J. Chanock, Gilles Thomas - Nature Genetics 2007 被引用: 1,133
- Beta-catenin mutations in human prostate cancer.
著者: Heinz Voeller, C. Truica, Edward P. Gelmann - 1998 被引用: 365
- A molecular correlate to the Gleason grading system for prostate adenocarcinoma
著者: Lawrence D. True, Ilsa M. Coleman, Sarah Hawley, Ching-Ying Huang, David Gifford, Roger Coleman, Tomasz M. Beer, Edward P. Gelmann, Milton W. Datta, Elahe A. Mostaghel, Beatrice S. Knudsen, Paul H. Lange, Robert L. Vessella, Daniel W. Lin, Leroy Hood, Peter S. Nelson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 被引用: 291
- β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription
著者: Liang‐Nian Song, Roger Herrell, Stephen W. Byers, Salimuddin Shah, Elizabeth M. Wilson, Edward P. Gelmann - Molecular and Cellular Biology 2003 被引用: 166
